You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啟明醫療(02500.HK)急漲近11% 擬折讓2.6%配新股淨籌逾14億加快產品研發
阿思達克 01-22 14:40
啟明醫療-B(02500.HK)折讓2.6%配股淨籌逾14億元,該股連升第六天,今天急漲10.6%,報90.9元,股價直逼去年10月所創紀錄高位97元,成交倍增至870萬股,涉資7.6億元。

啟明是內地領先的經導管心臟瓣膜醫療器械商,股份於去年底以每股33元來港上市。公司宣布,擬以每股80.08元(僅較昨天收市價折讓2.6%)配售1,804.25萬股新H股或佔擴大後已發行H股總數約4.18%,料所得款項淨額約14.27億元,將用作加快公司於研產品開發及研究,其中包括Venus PowerX Valve、Venus Vitae Valve、臨床前階段主動瓣膜修復裝置(Leaflex)、經導管二尖瓣置換術(TMVR)、經導管三尖瓣置換術(TTVR)等產品和技術,以及其他新技術開發和投資等運營資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account